What Qualifies for Inclusion
The Nasdaq 100, launched in February 1985, holds the 100 largest non-financial companies listed on the Nasdaq exchange. Banks, brokerages and insurance underwriters are excluded by rule, which tilts the index toward technology, communications, consumer discretionary and biotechnology. Eligibility requires seasoning on the exchange, adequate float and dollar volumes, and continued listing compliance, with contenders ranked annually and changes effective the third Friday of December.
The index first closed above 20,000 in late 2024, having spent 2022 in a bear market and 2023 recovering the entire move. Older history deserves equal respect: it fell more than 80 percent from the 2000 peak and needed fifteen years to reclaim that high, a record every leveraged participant should memorize before touching the product.
The Concentration Problem
By 2024 the ten largest weights exceeded half the index, a level no major benchmark had carried before. The Magnificent Seven of Microsoft, Apple, Nvidia, Amazon, Alphabet, Meta and Tesla together approached half the entire weight late that year. Buying the index meant buying the AI trade whether intended or not, and the 54 percent gain of 2023 was largely a mega-cap story, just as the 33 percent loss of 2022 had been.
Nvidia alone went from a mid-single-digit weight to the index heavyweight in under two years as data center spending exploded. Benchmarks built to measure the market became concentrated bets on a handful of AI capital budgets, and every passive dollar now amplifies that tilt.
Rebalance Rules and the Special Mechanism
Beyond annual reconstitution, the methodology empowers special rebalances when concentration thresholds are breached, and one was triggered in July 2023 to trim the largest positions after the AI rally pushed them past the concentration caps. That is portfolio construction by decree rather than market force, and it matters to futures traders because rebalance flows are forecastable, calendar-driven supply and demand in the biggest names. December rolls concentrate futures liquidity and occasionally widen spreads in underlying shares, which is when calendar-aware traders either flatten or embrace the volume.
Futures Versus ETF Exposure
The CME lists the full-size NQ contract at 20 dollars per index point and the micro MNQ at 2 dollars per point, letting a trader dial exposure from a few thousand dollars upward across nearly 23-hour sessions. The Invesco QQQ ETF holds the underlying basket for a 0.20 percent expense ratio, avoids expiry and roll costs, and suits positional exposure. Futures win on leverage efficiency; the ETF wins on simplicity and the absence of liquidation risk at expiry. Options trade on both.
Financing math decides the instrument more often than preference does. Futures embed interest in the basis and roll four times a year, while the ETF quietly deducts its fee and passes dividends through. For horizons under three months futures are usually cheaper, beyond a year the ETF wins, and in between the difference rarely justifies agonizing.
Position Sizing on MangkornEx
MangkornEx routes both micro futures and the ETF, so clients match the tool to the holding period rather than to habit. A MangkornEx rule of thumb holds that index exposure above 30 percent of a technology-heavy portfolio is concentration squared, because direct holdings likely already overlap the top ten names. Check margin screens before each December reconstitution if you carry futures through the roll. One micro at 21,000 index points controls 42,000 dollars of exposure, and one full NQ controls 420,000, so a trader who cannot state those numbers instantly is overleveraged by definition. The index remains the cleanest single-ticket bet on American large-cap innovation, and the discipline lies in respecting what a 35 percent drawdown does to leveraged positions.